Evidence map›Paper›PMID 33972400›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2021

Cereblon Regulates the Proteotoxicity of Tau by Tuning the Chaperone Activity of DNAJA1.

Uroos Akber, Heeji Jo, Seungje Jeon, Seung-Joo Yang, Sunhwa Bong, Sungsu Lim, Yun Kyung Kim, Zee-Yong Park, Chul-Seung Park

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. The CBEMBO molecular medicine · 2024
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Uroos AkberLaboratory of Molecular Neurobiology, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.ORCID https://orcid.org/0000-0003-3649-0673
Heeji JoLaboratory of Molecular Neurobiology, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Seungje JeonLaboratory of Molecular Neurobiology, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Seung-Joo YangLaboratory of Molecular Neurobiology, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Sunhwa BongLaboratory of Functional and Medicinal Proteomics, School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Sungsu LimCenter for Neuromedicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea.
Yun Kyung KimCenter for Neuromedicine, Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul 136-791, Republic of Korea.
Zee-Yong ParkLaboratory of Functional and Medicinal Proteomics, School of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea.
Chul-Seung ParkLaboratory of Molecular Neurobiology, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Republic of Korea cspark@gist.ac.kr.ORCID https://orcid.org/0000-0003-0209-1412
Gwangju Institute of Science and Technology · KRKorea Institute of Brain Science · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Protein aggregation can induce explicit neurotoxic events that trigger a number of presently untreatable neurodegenerative disorders. Chaperones, on the other hand, play a neuroprotective role because of their ability to unfold and refold abnormal proteins. The progressive nature of neurotoxic events makes it important to discover endogenous factors that affect pathologic and molecular phenotypes of neurodegeneration in animal models. Here, we identified microtubule-associated protein tau, and chaperones Hsp70 (heat shock protein 70) and DNAJA1 (DJ2) as endogenous substrates of cereblon (CRBN), a substrate-recruiting subunit of cullin4-RING-E3-ligase. This recruitment results in ubiquitin-mediated degradation of tau, Hsp70, and DJ2. Knocking out CRBN enhances the chaperone activity of DJ2, resulting in decreased phosphorylation and aggregation of tau, improved association of tau with microtubules, and reduced accumulation of pathologic tau across brain. Functionally abundant DJ2 could prevent tau aggregation induced by various factors like okadaic acid and heparin. Depletion of CRBN also decreases the activity of tau-kinases including GSK3α/β, ERK, and p38. Intriguingly, we found a high expression of CRBN and low levels of DJ2 in neuronal tissues of 5XFAD and APP knock-in male mouse models of Alzheimer's disease. This implies that CRBN-mediated DJ2/Hsp70 pathway may be compromised in neurodegeneration. Being one of the primary pathogenic events, elevated CRBN can be a contributing factor for tauopathies. Our data provide a functional link between CRBN and DJ2/Hsp70 chaperone machinery in abolishing the cytotoxicity of aggregation-prone tau and suggest that

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell LineDisease Models, AnimalHSP40 Heat-Shock ProteinsHumansMaleMiceNerve DegenerationTauopathiestau ProteinsUbiquitin-Protein LigasesAdaptor Proteins, Signal TransducingCRBN protein, humanCrbn protein, mouseDNAJA1 protein, humanDnaja1 protein, mouseHSP40 Heat-Shock Proteinstau ProteinsUbiquitin-Protein LigasescereblonchaperoneDNAJA1neurodegenerationtau phosphorylationubiquitin

Identifiers

PMID33972400
PMCPMC8211538
OpenAlexW3160496494

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.